Calamos Advisors LLC - EXAGEN INC ownership

EXAGEN INC's ticker is XGN and the CUSIP is 30068X103. A total of 37 filers reported holding EXAGEN INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of EXAGEN INC
ValueSharesWeighting
Q3 2021$160,000
-60.7%
11,768
-56.6%
0.00%
-50.0%
Q2 2021$407,000
-78.2%
27,141
-74.6%
0.00%
-80.0%
Q1 2021$1,871,000
+889.9%
106,947
+512.0%
0.01%
+900.0%
Q3 2020$189,000
-70.0%
17,474
-65.6%
0.00%
-75.0%
Q2 2020$631,000
-66.8%
50,794
-57.3%
0.00%
-73.3%
Q1 2020$1,898,000
-65.5%
119,071
-45.1%
0.02%
-44.4%
Q4 2019$5,505,000
+136.9%
216,802
+44.6%
0.03%
+107.7%
Q3 2019$2,324,000149,9770.01%
Other shareholders
EXAGEN INC shareholders Q4 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 858,567$9,985,0004.58%
PERKINS CAPITAL MANAGEMENT INC 199,475$2,320,0001.57%
COWEN AND COMPANY, LLC 1,384,631$16,103,0001.46%
Penbrook Management LLC 88,600$1,030,0000.62%
Cowen Prime Advisors LLC 102,400$1,191,0000.40%
RTW INVESTMENTS, LP 821,414$9,553,0000.14%
PLATINUM INVESTMENT MANAGEMENT LTD 400,000$4,652,0000.13%
Nantahala Capital Management 186,936$2,174,0000.08%
First Bank & Trust 12,597$147,0000.06%
WASATCH ADVISORS LP 1,105,760$12,860,0000.05%
View complete list of EXAGEN INC shareholders